Tocris Bioscience社 2014年1月新製品
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
5102 | PLX 647 dihydrochloride | Potent dual Fms/KIT inhibitor |
4917 | M 25 | Potent Smoothened (Smo) receptor antagonist |
4865 | APY 29 | Inhibits IRE1α autophosphorylation; activates IRE1α endoribonuclease activity |
4689 | GSK J5 | Inactive isomer of GSK J4 (Cat. No. 4594); cell permeable |
4688 | GSK J2 | Inactive isomer of GSK-J1 (Cat. No. 4593) |
5022 | BMS 599626 dihydrochloride | Potent, selective EGFR and ErbB2 inhibitor |
4632 | TC-I 2000 | TRPM8 blocker |
5071 | NKY 80 | Adenylyl cyclase inhibitor |
5066 | ICA 121431 | Selective NaV1.3 and NaV1.1 blocker |
5054 | ME 0328 | Selective PARP-3 inhibitor |
4948 | CYM 50769 | Novel non-peptide NPBWR1 antagonist |
4907 | SN 2 | Selective TRPML3 channel activator |
4906 | JW 642 | Monoacylglycerol (MAGL) inhibitor |
4406 | 10058-F4 | Inhibits c-Myc-Max dimerization |
4756 | COR 170 | Selective CB2 receptor inverse agonist |
4452 | GGsTop | Inhibitor of γ-glutamyl transpeptidase (GGT) |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。